VST BIO Corporation Announces Series A Financing to Advance VB-001 and Adds William Sessa to Board of Directors
By SquaredTown on March 17, 2026
SAN DIEGO, March 17, 2026 /PRNewswire/ -- VST BIO Corporation ("VST BIO"), a biotechnology company developing stroke therapeutics, announces the closing of its Series A financing, led by Coefficient Giving, a philanthropic funder and advisor that partners with donors on cost-effective,...